Press Releases

 Filter by Provider

Discover the best meme coins to join now as Apeing leads with whitelist access, culture-driven momentum, early pricing signals, and growing 2025 attention

Announcing a new retail writing guide, created specifically for brands to communicate their news with clarity in 2026.  Delhi —

Kubota dealerships were ranked highest in the 2026 Pied Piper PSI® Internet Lead Effectiveness® (ILE®) Compact Tractor Industry Study, which measured dealership responsiveness to internet sales leads. Pied Piper submitted customer inquiries through 772 compact tractor dealership websites representing all major brands. Kubota dealerships achieved an average ILE score of 37 out of 100, while the total industry averaged 29, however both dropped five and four points respectively since the previous year’s study. Following Kubota in the rankings were TYM, Mahindra, John Deere, and Yanmar.

Coastal Bend LNG today announced it has selected KBR, Inc. (NYSE: KBR) and Técnicas Reunidas (IBEXC: TRE) for the front-end engineering and design (FEED) of their planned natural gas liquefaction and export facility along the Texas Gulf Coast. Upon positive final investment decision, KBR and Técnicas Reunidas will proceed to execute the engineering, procurement, and construction (EPC) phase of the project.

Mattel, Inc. (NASDAQ: MAT) unveiled today its first-ever autistic Barbie doll created with guidance from the autistic community to represent common ways autistic people may experience, process, and communicate about the world around them. This doll invites more children to see themselves represented in Barbie.

At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP).

Boulder, CO, Jan. 11, 2026 (GLOBE NEWSWIRE) -- Healthy Gut, a Boulder-based digestive health company, announced the release of an updated formulation of its Holozyme product, reflecting the company’s expanded focus on fructan sensitivity as a potential contributor to bloating among individuals who follow plant-forward or health-conscious diets.

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today released preliminary unaudited results for the fourth quarter and full year ended December 31, 2025. The Company expects the following:

Tow.Market today announced the launch of the world's first AI-powered, on-demand towing marketplace, bringing real-time dispatch, transparent pricing, and live tracking to a global industry that has remained largely manual and fragmented. The company also confirmed the opening of its Seed investment round to accelerate platform rollout and national expansion.

The latest research from Omdia reveals that total shipments of desktops, notebooks and workstations in Q4 2025 grew 10.1% to 75 million units. This brought full-year 2025 PC shipments to 279.5 million units, a 9.2% increase over 2024 volumes. Notebook (including mobile workstation) shipments reached 58.6 million units in Q4 and 220.4 million units in the full year, achieving 8% growth in 2025. Desktop (including desktop workstation) shipments in Q4 landed at 16.2 million units, bringing the total 2025 volume to 59 million units, a 14.4% increase over the previous year.

At CES 2026, Geniatech unveiled its full-stack technological vision, with e-paper displays, edge AI computing, and ARM embedded solutions as its cornerstones. We are committed to accelerating the digital and sustainable transformation for industries worldwide, providing reliable, end-to-end innovation.

Bangkok, Thailand, January 12, 2026 -- TMD SPACE Launches “PDF Merge Files”: The Cutting-Edge Platform Redefining Document Security with Serverless, High-Privacy Technology

White Oak, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced it is sharing information about the agency’s flexible approach to overseeing chemistry, manufacturing and control (CMC) requirements for cell and gene therapies (CGT). The agency’s more flexible approach has been, and is expected to continue to be, helpful in expediting product development and will help guide the FDA’s evaluation of development strategies in preparation for a Biologics License Application (BLA) submission.  

FameWheels, an innovative automotive technology platform, expands with a comprehensive suite of services including digital auctions, vehicle inspections, and dealer solutions.

Auybovan Skincare launches a unique skincare line featuring ancient Sri Lankan botanicals, offering a simple 3-step routine that heals and rejuvenates with nature's most powerful botanicals.

Precision Algorithms unveils its advanced AI-powered platform designed to democratize high-level data analysis, offering predictive insights into sports, finance, and more, utilizing institutional-grade technology to level the playing field for all users.

The seventh stage, which marked the start of the second half of the Dakar Rally, brought both joy and trouble for the Buggyra ZM Racing team in the truck category.

FPT Software, the global IT services subsidiary of FPT Corporation (FPT), is positioned as a Leader in the IDC MarketScape: Asia/Pacific AI-Enabled Front Office Conversational AI Software 2025 Vendor Assessment (doc # AP52998625e, November 2025).

Bangkok, Thailand--(Newsfile Corp. - January 11, 2026) - TMD SPACE CO., LTD., a pioneer in the development of next-generation digital...

Bloom Pediatrics announces a new focus on helping neurodiverse children and teens overcome mood and behavioral challenges through natural, holistic Functional Medicine.

Chua will spearhead Health-ISAC’s expansion into the APAC region, enhancing cybersecurity and resilience in the global health sector

Ant International, a leading global payment, digitisation, and financial technology provider, is collaborating on the launch of Google’s Universal Commerce Protocol (UCP), a new open standard for agentic commerce that works across the entire shopping journey — from discovery and buying to post-purchase support.

Hong Kong, SAR--(Newsfile Corp. - January 11, 2026) - GitMind, a comprehensive platform for visual thinking and productivity tools, has...

CDB Aviation, a wholly owned Irish subsidiary of China Development Bank Financial Leasing Co., Ltd. (“CDB Leasing”), announced today that CDB Aviation Hong Kong (Limited), a Hong Kong incorporated entity wholly owned by CDB Aviation, executed a new Sustainability Linked Loan (“SLL”) transaction on December 19, 2025, anchored with a five-year $710 million unsecured term loan facility.

LOS ANGELES, Jan. 11, 2026 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based global shared intelligent electric mobility ecosystem company, today shared a weekly business update from YT Jia, Founder and Global Co-CEO of FF.

UPPF announced the grand opening of its Technical Center in Shanghai, a 3,000 sq ft facility designed to deliver faster, more comprehensive product support, strengthen quality management, and expand installation training for dealers and partners across Asia and beyond. The new center aligns with UPPF’s commitment to practical innovation and customer success, captured in the event theme: “Your Growth, Our Mission.”

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Sun Country Airlines Holdings, Inc. (NASDAQ: SNCY) to Allegiant Travel Company for 0.1557 shares of Allegiant common stock and $4.10 in cash for each Sun Country share is fair to Sun Country shareholders.

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Allegiant Travel Company (NASDAQ: ALGT) and Sun Country Airlines is fair to Allegiant shareholders. Upon completion of the proposed transaction, Allegiant shareholders will own approximately 67% of the combined company.

Short Summary Austin health insurance discussions are increasingly centered on strengthening community-based healthcare and nutrition support, emphasizing preventive care, in-home assistance, and sustainable solutions that help older adults maintain independence and overall well-being.

Richard Francis, Teva's President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 A.M. Pacific Time (11:15 A.M. Eastern Time)

– Reports $156 to $160 Million in Preliminary* Full-Year 2025 U.S. Net Product Sales, a 35% to 38% Increase Compared With Full-Year 2024 –

VANCOUVER, British Columbia, Jan. 11, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics, today outlined its strategic priorities and key milestones for 2026. Following a year of significant clinical, operational and financial progress, Zymeworks is focused on executing a long-term strategy designed to maximize value creation for patients, partners, and shareholders.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a record Total Contract Value (TCV) of >$1.1 billion as of December 31, 2025. During 2025, Tempus signed data agreements with over 70 customers, spanning both large and mid-sized pharma, including AstraZeneca, GlaxoSmithKline, Bristol Myers Squibb, Pfizer, Novartis, Merck, Abbvie, Daiichi Sankyo, Eli Lilly, Boehringer Ingelheim, and biotechs including Incyte, Servier, Aspera Biomedicines, and Whitehawk Therapeutics, as an increasing number of biopharma companies are incorporating Tempus’ unique, multimodal dataset into their drug discovery and development efforts.

NEW YORK and PARSIPPANY, N.J., Jan. 11, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced a funding agreement of up to $500 million to accelerate the clinical development of Teva’s anti-IL-15 antibody, TEV-'408. IL-15 is a key cytokine involved in multiple immune-mediated disease pathways. Emerging Phase 1b data from the ongoing TEV-‘408 vitiligo study provides preliminary support for IL-15 as a potential therapeutic target to treat a broad variety of autoimmune conditions. Teva anticipates sharing results from TEV-‘408 trials during 2026.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced select, preliminary, unaudited results for the fourth quarter and full year ended December 31, 2025.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced business and program updates ahead of upcoming investor meetings in January, including the company’s scheduled webcast from the 44th annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 5:15 p.m. ET/2:15 p.m. PT.

– Launched KOMZIFTI™ (ziftomenib), first and only once-daily, oral menin inhibitor approved for adults with R/R NPM1-mutated AML –

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced preliminary, unaudited results for the quarter and full year ended December 31, 2025.

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced its new five-year strategy, “Alnylam 2030,” focused on scaling the Company’s operations through achieving leadership in ATTR amyloidosis, driving long-term growth through sustainable innovation, and delivering exceptional financial results with discipline and agility. Alnylam also today reported preliminary* fourth quarter and full year 2025 global net product revenues for AMVUTTRA, ONPATTRO, GIVLAARI and OXLUMO.

Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) Based on Biomarker Endpoints

PARSIPPANY, N.J., and NEW YORK, Jan. 11, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Royalty Pharma plc (Nasdaq: RPRX), today announced a funding agreement of up to $500 million to accelerate the clinical development of Teva’s anti-IL-15 antibody, TEV-’408. IL-15 is a key cytokine involved in multiple immune-mediated disease pathways. Emerging Phase 1b data from the ongoing TEV-‘408 vitiligo study provides preliminary support for IL-15 as a potential therapeutic target to treat a broad variety of autoimmune conditions. Teva anticipates sharing results from TEV-‘408 trials during 2026.

Preliminary 2025 net product revenue of $155.4 million, representing 172% year-over-year growth; OJEMDA 2026 U.S. net product revenue projected to be $225 - $250 million

HealthEx is the first consumer health record integration for Claude by Anthropic to securely link comprehensive medical histories with user privacy and control

VICTORIA, Seychelles, Jan. 11, 2026 (GLOBE NEWSWIRE) -- Bitget has released a comparative review examining trading fees across leading cryptocurrency exchanges, offering a structured overview of how spot and derivatives trading costs differ among major platforms as global trading activity continues to scale.

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2025.

Aristocrat Leisure Limited (ASX:ALL) and Light & Wonder (ASX:LNW) have agreed to settle their pending litigation in Australia and the United States which Aristocrat brought following the launch of Light & Wonder’s Dragon Train game, which Aristocrat contends was developed using Aristocrat’s trade secrets and copyright works. Aristocrat later made similar claims against Light & Wonder’s Jewel of the Dragon game.